A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
Clinical trial NCT06838949 · RECRUITING
Trial details
- NCT number
- NCT06838949
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2026-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.